Immediate Impact

1 by Nobel laureates 1 from Science/Nature 67 standout
Sub-graph 1 of 24

Citing Papers

Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
2 intermediate papers

Works of J. Eugene Lewis being referenced

Phase II Trial of Intravenous Administration of Reolysin® (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma
2012

Author Peers

Author Last Decade Papers Cites
J. Eugene Lewis 246 143 47 134 12 441
J Karkov 51 227 39 173 9 476
Gordon R. MacDonald 191 48 36 92 13 418
Pia Asschenfeldt 104 121 29 25 15 409
Mary Jones 149 128 9 101 12 423
Brian Dillon 309 87 58 35 15 409
Tammy Naab 152 143 11 118 11 406
Ethel J. Gordon 91 47 9 86 15 508
F P Ryan 102 38 11 86 14 416
Ornella Carminati 77 324 20 48 13 435
Koji Nikkuni 89 212 14 48 22 450

All Works

Loading papers...

Rankless by CCL
2026